Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Efficacy and safety of mavacamten for the treatment of hypertrophic cardiomyopathy: an updated systematic review and meta-analysis of randomized controlled trials.

Autor: Almansouri NE; Department of Medicine, University of Tripoli, Tripoli, Libya., Nadeem Bukhari SAU; Department of Medicine, FMH College of Medicine and Dentistry., Qureshi MH; Department of Medicine, CMH Lahore Medical College., Idrees M; Department of Medicine, Multan Institute of Kidney Diseases, Multan., Riaz CZ; Department of Medicine, Madinah Teaching Hospital., Asghar AR; Department of Medicine, CMH Lahore Medical College., Habib A; Department of Medicine, Faisalabad Medical University, Faisalabad., Ikram J; Department of Medicine, Lifecare Hospital & Research Institute, Peshawar, Pakistan., Ehsan M; Department of Medicine, King Edward Medical University, Lahore., Rehman WU; Department of Medicine, United Health Services, Johnson City, New York., Cheema HA; Department of Medicine, King Edward Medical University, Lahore., Ayyan M; Department of Medicine, King Edward Medical University, Lahore., Kandel K; Department of Medicine, Kathmandu University, Nepal., Iqbal S; DMC Sinai Grace Hospital, Detroit, MI., Pasha A; Heart and Vascular Institute, United Health Services, Johnson City, NY., Patel K; Heart and Vascular Institute, United Health Services, Johnson City, NY., Sabouni MA; Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL, USA.

Publikováno v: Annals of medicine and surgery (2012) [Ann Med Surg (Lond)] 2024 Aug 22; Vol. 86 (10), pp. 6097-6104. Date of Electronic Publication: 2024 Aug 22 (Print Publication: 2024).